Evaluation of Serum hs-CRP Levels in Patients with Helicobacter pylori Infection Confirmed by Non-Invasive Tests
Archives of Advances in Biosciences,
Vol. 17 No. 1 (2026),
28 April 2026
,
Page 1-6
https://doi.org/10.22037/aab.v17i1.53277
Abstract
Background and Aim: Diagnosing Helicobacter pylori infection non-invasively remains a challenge, and upper endoscopy is often relied upon unnecessarily. This study aimed to assess the diagnostic accuracy of combining high-sensitivity C-reactive protein (hs-CRP) with a standard non-invasive test, the urea breath test (UBT), and to compare the results with the stool antigen (Stool Ag) test, in order to improve diagnostic accuracy and reliability and to reduce dependence on diagnostic upper endoscopy.
Methods: The study included 150 patients with dyspeptic symptoms (89 males, 59.3%; 61 females, 40.7%), with a mean age of 34.19 years. Statistical analyses were performed using IBM SPSS Statistics and included Welch’s t-test, Fisher’s exact test, and ROC analysis to determine diagnostic performance and optimal cut-off points. UBT was used as the validated reference standard against which hs-CRP and the Stool Ag test were compared.
Results: UBT showed a positivity rate of 98%. Mean hs-CRP was significantly higher in the positive group (67.52 ± 38.11 mg/L) than in the negative group (0.96 ± 0.81 mg/L; p < 0.001, Welch’s t-test). On ROC analysis, hs-CRP yielded an AUC of 1.000, indicating optimal predictive performance at a threshold of >10 mg/L, with 97.28% sensitivity and 100% specificity. The kappa value of 0.588 indicated moderate agreement between the diagnostic methods used.
Conclusion: Although hs-CRP is a broad indicator of systemic inflammation rather than a pathogen-specific diagnostic test, its evaluation alongside UBT may reflect the magnitude of the associated inflammatory response in symptomatic patients.
- Helicobacter pylori
- High sensitivity C reactive protein
- Urea breath test
- Stool antigen test
How to Cite
References
1. Chen Y, Pan X, Wang Y, Lin L, Chen X, Chen Y, et al. Prevalence and risk factors of helicobacter pylori infection in urban children aged 6–13 years in fuzhou china: a cross-sectional study in a high gastric cancer incidence region. Front Pediatr. 2025;13:1457195. (DOI: 10.3389/fped.2025.1457195) (PMID)
2. Pradhan SP, Gadnayak A, Pradhan SK, Epari V. Epidemiology and prevention of gastric cancer: a comprehensive review seminars in oncology volume 52 Issue 3. 2025;152341. (DOI: 10.1016/j.seminoncol.2025.152341) (PMID)
3. Garcés-Durán R, Llach J, Da Fieno A, Córdova H, Fernández-Esparrach G. Endoscopic diagnosis of h. pylori infection. Gastroenterol Hepatol. 2023;46(6):483-8. (DOI: 10.1016/j.gastrohep.2022.09.008) (PMID)
4. Kajihara Y, Shimoyama T, Mizuki I. Evaluation of the effects of a proton pump inhibitor on helicobacter pylori stool antigen testing. Helicobacter. 2023;28(3):e12961. (DOI: 10.1111/hel.12961)
5. Said ZNA, El-Nasser AM. Evaluation of urea breath test as a diagnostic tool for helicobacter pylori infection in adult dyspeptic patients. World J Gastroenterol. 2034;30(17):2302–07. (DOI: 10.3748/wjg.v30.i17.2302) (PMID)
6. Abdullah D. Alotaibi; c-reactive protein levels in patients with isolated inflammatory bowel disease (crohn’s disease and ulcerative colitis) and coexisting h. pylori infection and ibd: a comparative study. Inflamm Intest Dis. 2025;10(1):318–28. (DOI: 10.1159/000548449) (PMID)
7. Kurihara C, Kerpel-Fronius S, Becker S, Chan A, Nagaty Y, Naseem S, et al. matsuyama k and baroutsou v declaration of helsinki: ethical norm in pursuit of common global goals. Front Med. 2024;11:1360653. (DOI: 10.3389/fmed.2024.1360653) (PMID)
8. Andrawes M, Andrawes W, Das A, Siau K. Proton pump inhibitors (ppis)—an evidence-based review of indications efficacy harms and deprescribing. Med. 2025;61(9):1569. (DOI: 10.3390/medicina61091569) (PMID)
9. Biter S, Turk I, Varkal G, Dinkçi S, Erken E. Investigation of the frequency of crp gene polymorphism in rheumatoid arthritis and associations with crp level and clinical involvements of the disease. Balkan J Med Genet. 2025;28(1):20250003. (DOI: 10.2478/bjmg-2025-0003) (PMID)
10. Huang J, Xie Y, Huang J, Lu B, Chen Y. Accuracy and agreement of a 45 mg versus a 75 mg 13c-urea breath test for the diagnosis of helicobacter pylori Infection in adults: a randomized crossover trial. Diagnostics. 2026;16(10):1567. (DOI: 10.3390/diagnostics16101567) (PMID)
11. Silva LuzM, Tianeze de Castro C, Bueno Lemos FF, Reis Rocha G, Lima Correa Santos G, Rocha Pinheiro SL, et al. Stool antigen test for helicobacter pylori infection in adults: a meta-analysis of diagnostic test accuracy. J Clin Gastroenterol. 2024;59(5):393–404. (DOI: 10.1097/MCG.0000000000002102) (PMID)
12. Rahali FZ, Mimouni N, Boukhira A. et al. The clinical utility of standard and high-sensitivity c-reactive protein: a narrative review. SN Compr Clin Med. 2024;6:65. (DOI: 10.1007/s42399-024-01693-3)
13. IBM Corp. Ibm spss statistics for windows version 31.0. armonk. NY: IBM Corp. 2025. Link
14. Karimi M, Karimi Z, Khosravi M, Delaram Z, Dehsheikhim MH, Najafabadi SA, et al. Feature selection methods in big medical databases: a comprehensive survey. Int J Theor Appl Comput Int. 2025;181–209. (DOI: 10.65278/IJTACI.2025.21)
15. Riesthuis P, Otgaar H. On the use of receiver operating characteristic area under the curve in eyewitness memory research. Leg Criminol Psychol. 2025;30:212–30. (DOI: 10.1111/lcrp.12300)
16. Yan L, He Q, Peng X. et al. Prevalence of helicobacter pylori infection in the general population in wuzhou china: a cross-sectional study. Infect Agents Cancer. 2025;20(1):1. (DOI: 10.1186/s13027-024-00632-0) (PMID)
17. Laven R, Yang DA. Yang, Common misinterpretations of statistical significance and P-values in dairy research, JDS Commun, 2025;6(6):721-26. (DOI: 10.3168/jdsc.2025-0835) (PMID)
18. Gasimova M, Gurbanov A, Kadyrova A, Huseynov R, Narimanov V. Diagnostic potential of non-invasive tests for helicobacter pylori-associated gastroduodenal disease in a resource-limited laboratory setting. Diagn Microbiol Infec Dis. 2026;114(2):117167. (DOI: 10.1016/j.diagmicrobio.2025.117167) (PMID)
19. Zhang T, Zheng Y, Chen T, et al. Biomaterials mediated 3r (remove-remodel-repair) strategy: holistic management of Helicobacter pylori infection. J Nanobiotechnol. 2025;23(1):475. (DOI: 10.1186/s12951-025-03455-2) (PMID)
20. Hussin HA, Rufaish HNJ. Serum interleukin-8 high-sensitivity c-reactive protein and gastrin-17 in helicobacter pylori-positive dyspepsia: a cross-sectional case–control study from al-najaf iraq. Karbala J Pharm Sci. 2026;17(28):203-23. (DOI: 10.62472/kjps.v17.i28.203-223)
21. Ahmed EA, Nooruldeen DA, Abdullah MK, Abdullah HK. Comparison between urea breath test and stool antigen test for diagnosis of helicobacter pylori in children and adolescent in erbil city. Adolesc Saúde, 2026;21(3s):1–6. (DOI: 10.67440/ahj.v21i3s.997)
22. Omar M, Abu-Salah R, Agbareia R, Sharif Y, Levin R, Lahat A, et al. A comparative systematic review and meta-analysis on the diagnostic accuracy of non-invasive tests for helicobacter pylori detection in elderly patients. Front Med. 2023;10:1323113. (DOI: 10.3389/fmed.2023.1323113) (PMID)
23. Vanbelle S, Engelhart CH, Blix E. Measuring agreement in diagnostics: a practical guide for researchers. Stat Med. 2025;44(23-24):e70299. (DOI: 10.1002/sim.70299) (PMID)
24. Ibrahim BM, Salman HS, Mohammed MM, Mjeed HM. Prevalence of helicobacter pylori infection among dyspeptic patients attending baghdad medical city complex. Iran J Microbiol. 2025;17(3):397–403. (DOI: 10.18502/ijm.v17i3.18822) (PMID)
25. Raso T, D’Arcangelo G, Renzo S, Strisciuglio C, Colucci A, Saccomani MD, et al. Diagnostic accuracy of non-invasive tests for helicobacter pylori infection in children: a multicenter retrospective study by sigenp. Dig Liver Dis. 2026;58(1):82-7. DOI: 10.1016/j.dld.2025.11.013)
- Abstract Viewed: 0 times
- PDF Downloaded: 0 times